ArticleHuman vaccines & immunotherapeutics2025

Pharmacovigilance analysis of FcRn antagonists in the treatment of myasthenia gravis: A disproportionality analysis based on the FAERS database.

Boyi Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.